OBSOLETE: Envenomization by Bothrops lanceolatus

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:1939
Who is this for?
Show terms as
2FDA treatments8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Envenomization by Bothrops lanceolatus refers to poisoning caused by the bite of the Martinique lancehead pit viper (Bothrops lanceolatus), a venomous snake found exclusively on the Caribbean island of Martinique. This is not a genetic disease but rather a medical condition resulting from snakebite envenomation. This entry is marked as 'OBSOLETE' in the Orphanet database, meaning it is no longer actively classified as a rare disease entry, likely because it is better categorized as a toxicological emergency rather than a rare disease. When a person is bitten by this snake, the venom can cause serious problems throughout the body. The venom of Bothrops lanceolatus is unusual compared to other pit vipers because it is particularly associated with blood clotting complications, including thrombosis (formation of blood clots in blood vessels). Victims may experience local symptoms at the bite site such as severe pain, swelling, and tissue damage. More dangerously, the venom can trigger clot formation in blood vessels supplying the brain, lungs, and other organs, potentially leading to stroke, heart attack, or organ failure. Treatment involves emergency medical care, including the use of specific antivenom (Bothrofav, produced by the Institut Pasteur) when available, supportive care, and management of clotting complications. Prompt medical attention is critical to prevent life-threatening outcomes. Without treatment, envenomation can be fatal or lead to permanent disability.

Also known as:

Key symptoms:

Severe pain at the bite siteSwelling around the biteBruising and skin discoloration near the woundTissue death around the bite areaBlood clots forming in blood vesselsStroke symptoms such as sudden weakness or speech difficultyDifficulty breathingNausea and vomitingHeadacheBleeding from the wound that is hard to stopOrgan damage from blood clotsLow blood pressureRapid heartbeat

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

FDA & Trial Timeline

2 events
May 2015

Anavip: FDA approved

Management of adult and pediatric patients with North American rattlesnake envenomation

FDAcompleted
Oct 2000

CroFab: FDA approved

Treatment of minimal and moderate North American Crotalidae envenomation

FDAcompleted

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

2 available

Anavip

crotalidae immune F(ab')2 (equine)· Rare Disease Therapeutics, Inc.Orphan Drug

Management of adult and pediatric patients with North American rattlesnake envenomation

CroFab

Antivenin, crotalidae polyvalent immune Fab (ovine)· Protherics, Inc.Orphan Drug

Treatment of minimal and moderate North American Crotalidae envenomation

No actively recruiting trials found for OBSOLETE: Envenomization by Bothrops lanceolatus at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the OBSOLETE: Envenomization by Bothrops lanceolatus community →

No specialists are currently listed for OBSOLETE: Envenomization by Bothrops lanceolatus.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to OBSOLETE: Envenomization by Bothrops lanceolatus.

Search all travel grants →NORD Financial Assistance ↗

Community

Open OBSOLETE: Envenomization by Bothrops lanceolatusForum →

No community posts yet. Be the first to share your experience with OBSOLETE: Envenomization by Bothrops lanceolatus.

Start the conversation →

Latest news about OBSOLETE: Envenomization by Bothrops lanceolatus

No recent news articles for OBSOLETE: Envenomization by Bothrops lanceolatus.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.Was antivenom administered, and was it given in time to be effective?,Are there any signs of blood clots in my brain or other organs?,What follow-up tests do I need to check for delayed complications?,How should I care for the bite wound at home?,What symptoms should prompt me to return to the emergency room?,Will I have any long-term effects from this envenomation?,How can I reduce my risk of future snake bites on Martinique?

Common questions about OBSOLETE: Envenomization by Bothrops lanceolatus

What is OBSOLETE: Envenomization by Bothrops lanceolatus?

Envenomization by Bothrops lanceolatus refers to poisoning caused by the bite of the Martinique lancehead pit viper (Bothrops lanceolatus), a venomous snake found exclusively on the Caribbean island of Martinique. This is not a genetic disease but rather a medical condition resulting from snakebite envenomation. This entry is marked as 'OBSOLETE' in the Orphanet database, meaning it is no longer actively classified as a rare disease entry, likely because it is better categorized as a toxicological emergency rather than a rare disease. When a person is bitten by this snake, the venom can cause

What treatment and support options exist for OBSOLETE: Envenomization by Bothrops lanceolatus?

2 patient support programs are currently tracked on UniteRare for OBSOLETE: Envenomization by Bothrops lanceolatus. See the treatments and support programs sections for copay assistance, eligibility, and contact details.